FDA NDC Directory · JSON-LD · Markdown

Halaven

NDC 43624-002 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameeribulin mesylate
Labeler / ManufacturerBSP Pharmaceuticals SpA
Marketing categoryNew Drug Application (innovator) · App NDA201532
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsERIBULIN MESYLATE (1 mg/2mL)
Marketing started20170421
Package count1

External sources

Source: openFDA. Public-domain (CC0).